Macquarie upgraded Healthcare Services (HCSG) to Outperform from Neutral with a price target of $16, up from $15. The firm sees upside from stable industry fundamentals, growth momentum, and enhanced capital return. Macquarie also believes the accelerating growth trend is sustainable as the company executed well on sales and retentions despite noise around Genesis.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCSG:
